PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Effective management of patients who are at risk of developing invasive cancer is a primary challenge in early cancer
detection. Techniques that can help establish clear-cut protocols for successful triaging of at-risk patients have the
potential of providing critical help in improving patient care while simultaneously reducing patient cost. We have
developed such a technique for early prediction of cancer progression that uses unstained tissue sections to provide
depth-resolved nanoscale nuclear architecture mapping (nanoNAM) of heterogeneity in optical density alterations
manifested in precancerous lesions during cancer progression. We present nanoNAM and its application to predicting
cancer progression in a well-established mouse model of spontaneous carcinogenesis: ApcMin/+ mice.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Shikhar Uttam, Hoa V. Pham, Justin LaFace, Douglas J. Hartman, Yang Liu, "Depth-resolved nanoscale nuclear architecture mapping for early prediction of cancer progression," Proc. SPIE 9697, Optical Coherence Tomography and Coherence Domain Optical Methods in Biomedicine XX, 969728 (8 March 2016); https://doi.org/10.1117/12.2214688